$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Ceritinib/Ceritinib (Zanda) detailed instructions and precautions for use
2026-02-01 22:25:32
Check Details
Common side effects of Bestivan (Vilire) and patient medication safety management
2026-02-01 22:25:32
Check Details
Dabrafenib (Tefila) efficacy and effects and patients’ actual efficacy feedback
2026-02-01 22:25:32
Check Details
Will Axitinib be included in the 2025 medical insurance catalog and its reimbursement ratio?
2026-02-01 22:25:32
Check Details
Safety and precautions for long-term use of avatrombopag (Sucoxin)
2026-02-01 22:25:32
Check Details
Can Gilteritinib be taken with food and dietary precautions
2026-02-01 22:25:32
Check Details
What kind of drugs does pirfenidone (Asri) belong to and its pharmacological mechanism of action
2026-02-01 22:25:32
Check Details
The domestic launch time and approval information of canafenib/encofenib
2026-02-01 22:25:32
Check Details
Imatinib (Gleevec) detailed instructions and medication instructions analysis
2026-02-01 22:25:32
Check Details
Which is better, the Hong Kong version or the Bangladeshi version of ruxolitinib cream (Opzelura) and analysis of their respective advantages
2026-02-01 22:25:32
Check Details
Analysis of which diseases Epclusa is suitable for and its clinical treatment effect
2026-02-01 22:25:32
Check Details
Differences and price comparison between imported and domestic drugs Sunitinib
2026-02-01 22:25:32
Check Details
1
2
...
2019
2020
2021
2022
2023
2024
2025
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma